Dr. David Matthew Richards, MD

Dr. Richards practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Richards' NPI, 1770719064, was assigned on June 1, 2009. Dr. Richards graduated from Wayne State University School Of Medicine in 2006. Dr. Richards holds Texas license N2756.

Dr. Richards' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Richards' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Richards is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richards practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Richards' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Richards is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Richards' licenses on file in 11 states: Texas, Florida, Georgia, Tennessee, Mississippi, Washington, Alabama, Arizona, Louisiana, Oklahoma and Michigan.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Richards treats.

CMS data shows 623 Medicare services from Dr. Richards across 15 procedure codes in 2024, for 399 Medicare patients. Medicare paid $46,870 for them.

CMS counts 399 Medicare patients who saw Dr. Richards in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Richards' median patient age at 70, with 54% women.

In 2024, Dr. Richards wrote 169 Medicare Part D claims for 65 patients. 83% of them were for generic drugs. CMS names the drug for 87 of them, across 2 drugs with 11 or more claims each, at $736 in total drug cost. In 2023, CMS named 154 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Richards for performance year 2024, reported as part of a group. Dr. Richards accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Richards as offering telehealth. CMS counts 222 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Richards, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Richards, published from 2010 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Colitis, Biopsy and Colonoscopy. Dr. Richards has published most often in Dig Dis Sci. Dr. Richards' most frequent co-authors are Gottumukkala S. Raju, MD, Yinghong Wang, MD, PhD and Noman N. Ali, MD.

CMS Open Payments shows 60 general payments to Dr. Richards from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. CONMED Corporation paid the most, $281.

Dmand AI lists 1 award for Dr. Richards, most recently CMS Stage 1 EHR in 2013.

Dr. Richards graduated from Wayne State University School Of Medicine in 2006. Dr. Richards is a member of ACG, AGA, American Neurogastroenterology and Motility Society, ASGE and TMA.

Dr. Richards is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.